Not exact matches
A one - time intravenous infusion
of the high dose
of gene therapy extended the survival
of patients with spinal muscular atrophy
type 1 (SMA1) in a Phase 1 clinical trial, according to a study published in the
New England Journal
of Medicine.
The
new method may make some
types of gene therapy easier and could be a boon for researchers hoping to control
gene activity in animals, scientists say.
The
new method may make some
types of gene therapy easier...
April 23, 2018 Ultragenyx Announces Filing and FDA Clearance
of an Investigational
New Drug Application for DTX401, a
Gene Therapy for the Treatment
of Glycogen Storage Disease
Type Ia
«The ability to direct a
gene to a specific cell
type and prevent expression in other cell
types is a powerful
new tool that allows us to bypass one
of the most troubling safety concerns facing
gene therapy,» said Michael Parmacek, MD, assistant professor
of medicine at the University
of Chicago and director
of the study.
«This
new work is exciting, because it shows that we can directly target
genes within a specific cell
type, which is important for targeted
therapies,» says Hedrick, a Professor in the Division
of Inflammation Biology.